Treating Hereditary Rare Diseases With In Vivo Precision Genetic Medicines (THRIVE)

This solicitation requires a detailed proposal addressing a significant technical challenge, including a synopsis of the proposed work, its limitations compared to current approaches, and the competitive landscape. Proposals must outline key technical risks and mitigation strategies, demonstrate alignment with the THRIVE ISO, and detail any new technical developments required for success. Additionally, proposers must provide information regarding organizational capabilities, including experience, intellectual property, facilities, and a commercialization plan, including an IP strategy. Proposals must also include a detailed coordination plan with risk management approaches, documentation of formal teaming agreements, and a Project Management Institute (PMI) candidate resume or qualification description. Specific information regarding points of contact, cost share, and place(s) of performance are also required, as well as adherence to specified size standards.

Notice ID

15d91a5d930f4e60abab26011151da4c

Solicitation Number

ARPA-H-SOL-25-122

NAICS Code

541714

Classification Code

AN13